Bookmark this section you'll come back to it
For the most current information on ongoing or recruiting trials, visit ClinicalTrials.gov: Tirzepatide Trials SURPASS Program: Type 2 Diabetes Trials The SURPASS (Tirzepatide Once Weekly for the Treatment of Obesity) clinical trial program evaluated tirzepatide 5 mg, 10 mg, and 15 mg weekly for glycemic control in type 2 diabetes
This is the practical reason a reader who is nervous about small-volume accuracy might prefer the 50 mg protocol the trade-off being that each vial carries fewer total doses, as the supply math shows next
Collectively, these constraints support a measured translational posture that prioritises selected high-need indications, simplified assays with standardised pipelines, and multi-centre prospective validation over premature deployment in unselected populations [483, 486]
It's important to tell your provider about everything you're taking, including prescription drugs, over-the-counter products, and supplements